Adam Laing
Company: Melio Health
Job title: CSO
Seminars:
IMU: Population Scale Immune Profiling for Donor Selection, Patient Stratification, and Patient Monitoring in Cell Therapy 9:00 am
day: Day Two
Panel Discussion: Defining a ‘Super-Donor’ & Discussing Cell Source Considerations to Maximize Off-the-Shelf Product Quality 12:00 pm
Identifying and characterizing the most robust sources and donors Questioning what constitutes a ‘super-donor’: the percentage of gamma delta T cells in circulation, or other markers at play Managing donor selection, variation, and evolving process development for each donor Developing a master cell bank for scalable, consistent, offthe- shelf productsRead more
day: Day 2 am track a